Merestinib T3455
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LY2801653 is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity. LY2801653 selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transducti
CAS nr:
1206799-15-6
Purity:
98%
Molecular Weight:
552,54
SMILES:
c1(=O)c(ccc(n1c1ccc(cc1)F)C)C(=O)Nc1cc(c(cc1)Oc1cc2cnn(c2cc1c1cn[nH]c1)C)F
Formula:
C30H22F2N6O3
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Immunology/Inflammation,Tyrosine Kinase/Adaptors
Target:
FLT,FLT,c-Met/HGFR,ROS,Discoidin Domain Receptor (DDR)
